Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.33 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 2/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | BAX | Q07812 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL932517 | 0.76 | LTA4H (0.45) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL991332 | 0.76 | LTA4H (0.45) | LTA4HTSHRTDP1CA4KCNA3 | |
| SCHEMBL195629 | 0.74 | LTA4H (0.43) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL195903 | 0.74 | LTA4H (0.43) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL28048701 | 0.73 | LTA4H (0.38) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL7615332 | 0.72 | LTA4H (0.41) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL3946937 | 0.72 | LTA4H (0.48) | LTA4HTSHRTDP1CA4KCNA3 | |
| SCHEMBL1264005 | 0.72 | TDP1 (0.41) | LTA4HTSHRCYP3A4TDP1CA4 | |
| SCHEMBL12949871 | 0.72 | TSHR (0.38) | TSHRCYP3A4KMT2AALDH1A1 | |
| SCHEMBL11664687 | 0.71 | LTA4H (0.36) | LTA4HTSHRCYP3A4TDP1CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7767852-B2 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-03 | — | — | US | disclosed |
| US-20080083606-A1 | preparing aminodihalophosphines, diaminohalophosphines, triaminophosphines, phosphorous ester diamides, aminophosphines, diaminophosphines, phosphorous ester amide halides and aminophosphine halides with elimination of an acid in the presence of an auxiliary base | BASF AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | US | disclosed |
| CN-1300156-C | Method for separating acid from chemical reaction mixture by using ionic liquid | BASF AG (DE) | 2007-02-14 | — | — | CN | disclosed |
| CN-1622948-A | Method for separating acid from chemical reaction mixture by using ionic liquid | BASF AG (DE) | 2005-06-01 | — | — | CN | disclosed |
| US-20050020857-A1 | Removal by salt formation | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050020857-A1 | Removal by salt formation | PHOSPHO1, AASDHPPT, INPP5B | LTA4H 3084/4885TSHR 1936/4885CYP3A4 4671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.